Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.
about
Current status of theranostics in prostate cancer.Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.PSMA Theranostics: Current Status and Future Directions.Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine
P2860
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@ast
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@en
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@nl
type
label
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@ast
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@en
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@nl
prefLabel
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@ast
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@en
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@nl
P2093
P2860
P1476
Repeated PSMA-targeting radiol ...... ate cancer with 131I-MIP-1095.
@en
P2093
Christian Zechmann
Clemens Kratochwil
Fabian Spohn
John Babich
Nils Debus
Thomas Armor
Tim Holland-Letz
Uwe Haberkorn
P2860
P2888
P304
P356
10.1007/S00259-017-3665-9
P577
2017-03-09T00:00:00Z